Iodine seed (I-125) as a marker in lung-lesions

Iodine seed (I-125) as a marker in lung-lesions - Iodine seed (I-125) as a marker in lung-lesions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON35843

Enrollment

Registered

2011-07-06

Start date

2011-09-02

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrathoracaal (en intraparenchymaal) gelegen longafwijkingen (benigne en maligne) Unidentified lung-lesion

Interventions

Implant of a I-125 marker (radio-active seed).

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Lung lesion wthout a diagnosis with an indication for surgical biopsy

Exclusion criteria

Exclusion criteria: No exclusion criteria

Design outcomes

Primary

Measure	Time frame
Peroperative localisation	—

Secondary

Measure	Time frame
Implant procedure Pathological analysis	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)